The Role of Regulated Necrosis in Endocrine Diseases

Total Page:16

File Type:pdf, Size:1020Kb

The Role of Regulated Necrosis in Endocrine Diseases PERSPECTIVES system results in the typical morphological features such as rapid shrinking of the cell, The role of regulated necrosis nuclear condensation, DNA fragmentation, exposure of phosphatidylserine and a in endocrine diseases process known as membrane blebbing11,12. Phosphatidylserine exposure functions Wulf Tonnus , Alexia Belavgeni , Felix Beuschlein , Graeme Eisenhofer, as an ‘eat me’ signal to macrophages13–15. Martin Fassnacht , Matthias Kroiss , Nils P. Krone, Martin Reincke , Importantly, the plasma membrane remains intact in apoptotically dying cells, Stefan R. Bornstein and Andreas Linkermann a mechanism that prevents the release of Abstract | The death of endocrine cells is involved in type 1 diabetes mellitus, intracellular content to the interstitial and/or autoimmunity, adrenopause and hypogonadotropism. Insights from research on extracellular space. Therefore, apoptosis is immunologically silent. The detection basic cell death have revealed that most pathophysiologically important cell death of apoptosis has been misinterpreted for is necrotic in nature, whereas regular metabolism is maintained by apoptosis decades by the TdT-mediated dUTP-biotin programmes. Necrosis is defined as cell death by plasma membrane rupture, which nick end- labelling (TUNEL) method (BOx 1). allows the release of damage- associated molecular patterns that trigger an Mechanistically, extrinsic apoptosis immune response referred to as necroinflammation. Regulated necrosis comes in is mediated by death receptors such as different forms, such as necroptosis, pyroptosis and ferroptosis. In this Perspective, tumour necrosis factor receptor 1 (TNFR1) or the FAS receptor (also known as with a focus on the endocrine environment, we introduce these cell death CD95)16. To kill a cell through a TNFR1 pathways and discuss the specific consequences of regulated necrosis. Given that signal, upon binding of the ligand TNF, clinical trials of necrostatins for the treatment of autoimmune conditions have the TNFR1 signalling complex dissociates already been initiated, we highlight the therapeutic potential of such novel from the plasma membrane. Within the therapeutic approaches that, in our opinion, should be tested in endocrine cytosol, the FAS-associated death domain protein (FADD)- bound initiator caspase 8 disorders in the future. is recruited to the complex and interacts with receptor- interacting protein kinase 1 Endocrine glands control the human of endocrine disorders7,8, including septic (RIPK1)17,18. In the case of TNFR1, body’s metabolism, vital functions, mental adrenal dysfunction, autoimmune diseases however, the default signal to activate the and physical adaptation to stress, and such as type 1 diabetes mellitus (T1DM)9 transcription factor NF-κB is maintained the capacity to reproduce. Regulated cell and endocrine malignancies. Both the through the recruitment of kinases (IKKε necrosis and cell proliferation define prevention of cell death by rescuing cells and TBK1) through linear polyubiquitin endocrine tissue development and that otherwise succumb to necrosis (as is chains on RIPK1 (REF.19) and does not homeostasis, as well as its capacity to the case in T1DM)9 and the induction of result in cell death. Mechanistically, TBK1 adapt to stress and to prevent tumour necrosis in endocrine cancers (such as with phosphorylates RIPK1 and thereby inhibits formation. The term regulated cell death adrenocortical carcinomas)10 might lead its autophosphorylation-induced activation, was used mostly synonymously with to therapeutic benefits. This Perspective which is required for cell death. However, apoptosis until 15 years ago. However, our therefore aims to summarize the existing upon activation of caspase 8, RIPK1 activity understanding of necrosis as a regulated data on the newly characterized cell death is prevented by proteolytic cleavage of RIPK1 process has dramatically expanded since pathways in endocrine disorders while by caspase 8 (REF.20). The proteolytically then. In the past 15 years, we have begun focusing on unanswered questions. We also active caspase 8 also cleaves the effectors to understand the details of necroptosis, discuss the need to revisit the literature caspase 3, caspase 6 and caspase 7 (REF.21), pyroptosis and ferroptosis1. Necrosis that was published before the identification which mediate the apoptotic cellular not only causes organ dysfunction but of necroptosis, pyroptosis and ferroptosis phenotype. As caspase 8 also controls the also results in an inflammatory response and reinterpret it in the light of the current activation of the pyroptosis pathway22, driven by damage-associated molecular understanding to highlight the possibility of it must be interpreted as the master regulator patterns (DAMPs), which is referred to as therapeutic interventions. of death receptor-mediated cell death. necroinflammation2,3. The control of extrinsic apoptosis and Studies have shown that the three The types of regulated cell death necroptosis (which is discussed in the next pathways of regulated necrosis, namely Apoptosis: well defined and well tolerated by section) by post- translational modification is necroptosis, pyroptosis and ferroptosis, can the immune system. Apoptosis (Fig. 1a) is the reviewed in more detail elsewhere23–25. be therapeutically targeted4–6. Accumulating default cell death pathway for homeostasis By contrast, loss of the mitochondrial data suggest that necroinflammation is of and cellular turnover during physiological outer membrane potential and the central relevance in the pathophysiology metabolism11,12. The caspase-controlled recruitment of BAX and BAK to the outer NATURE REVIEWS | ENDOCRINOLOGY VOLUME 17 | AUGUST 2021 | 497 0123456789();: PERSPECTIVES a Apoptosis Apoptotic vesicle b Necroptosis RHIM domain TNFR1 Exposure of TRAILR phosphatidylserine TLR TRADD P FAS casp8 TRIF TRADD M1 Ub P P RIPK1 NEMO P chain RIPK3 TANK P RIPK1 P P K63 FADD RIPK3 TAK1 OTULIN IKKε RIPK1 NEMO casp8 MK2 TBK1 TANK P IKKε Loss SHARPIN DD TBK1 of Ub Viral DNA HOIP casp8 c-FLIP chains CYLD BAK and/or RNA HSP90 A20 HOIL1 BAX cIAP1 P RIPK3 P MOMP P P cIAP2 LUBAC BID RIPK3 complex tBID P P RIPK3 MLKL P ? Cytochrome c P RIPK3 P SMAC CDC37 Extrinsic ZBP1 MLKL P Lysosome APAF1 Necrosome P XIAP RIPK3 P Nucleus RIPK3 MLKL P Degradation casp3 Intrinsic MLKL P Effector casp6 casp9 MLKL P caspases P casp7 P P MLKL P P P P MLKL P MLKL P MLKL Flotilin MLKL P MLKL MLKL P MLKL MLKL MLKL MLKL Apoptosis ESCRT-III MLKL P • Membrane MLKL P rupture MLKL P • DAMP release MLKL P MLKL P P Cell death MLKL Survival MLKL P MLKL P c Pyroptosis d Ferroptosis K+ efflux Glutamate Bacterium Potassium DAMPs System x – channel c Peroxisome SLC3A2 SLC7A11 Cystine casp8 ? ASC • 3 × Glutamate Cysteine ER • 4×ATP H O • 5 × Glycogen 2 2 NLRP3 POR and/or CYB5R1 NADPH 2 × GSH Casp1/11 Inflammasome GPX4 AA FA NADP+ GSR GSSG ASC c-FLIP 2+ ACSL4 Fe +H2O2 AA-CoA FA-CoA 2 Acetyl-CoA Fe3+ + HO + HO˙ casp1 casp8 III IV casp11 II Pro-IL-1β HMG-CoA PL-OOH I Pro-IL-18 HMGCR PL-OH GSDMD casp3 Mevalonate OXPHOS IL-1β Co-Q10 PE-AA-OOH C IL-18 Mevalonate pathway N FPP Prenylated Prominin 2 Lipid Ferritin proteins peroxidation MVB N-terminal Squalene Fe2+ GSDMD RTA Cholesterol Ferritin ESCRT-III • Membrane rupture FSP1 TSG101 and/or 2+ • DAMP release DAMP Ca AIFM2 release N ESCRT-III Ferritin Inflammation TSG101 N Cell death Cell death Membrane repair Ferroptosis N Survival mechanism sensitivity 498 | AUGUST 2021 | VOLUME 17 www.nature.com/nrendo 0123456789();: PERSPECTIVES ◀ Fig. 1 | Regulated cell death pathways at a glance. Apoptosis represents a non-inflammatory path- SHARPIN, HOIP and HOIL1, generates way that is mediated by caspases (part a). Two distinct signalling pathways of apoptosis, extrinsic and linear polyubiquitin chains59–61. The intrinsic apoptosis, have been characterized. While apoptosis depends on the activation of caspases, polyubiquitin chains are disassembled by necroptosis is mediated by kinases (part b). Dependent on its RHIM domain, RIPK3 forms an amyloid- the deubiquitinases (DUBs) referred to as like structure referred to as the necrosome, the central signalling platform of necroptosis. Therein, (REFS62,63) 20,64–67 RIPK3 phosphorylates the pseudokinase MLKL. By unknown mechanisms, the phosphorylated form of A20 and CYLD in the case of 68–70 MLKL (pMLKL) triggers plasma membrane rupture, a process that was demonstrated to be counter- K63 linkages and as OTULIN in the case acted by the membrane repair ESCRT- III complex. In contrast to apoptosis and necroptosis, inflam- of linear chains. It is this subtle equilibrium of masomes are involved in the initiation of cell death by pyroptosis (part c). The activation of caspases post- translational modification that (1, 4, 11) in inflammasomes results in the cleavage of pro- IL-1β, pro- IL-18 and gasdermin D (GSDMD). determines if the kinases IKKε and TBK1 Finally, and without any clear connection to apoptosis, necroptosis and pyroptosis, ferroptosis is a are recruited into the complex and prevent 71 failsafe rather than a typical cell death pathway (part d). In cellular homeostasis, H2O2 concentrations cell death signalling either by apoptosis or of iron-catalysed and Fenton reactions are limited by diverse cellular anti-redox systems. Glutathione by necroptosis19. In addition, the sensitivity to peroxidase 4 (GPX4) prevents lipid peroxidation that otherwise leads to plasma membrane rupture by necroptosis is further regulated on different unknown mechanisms. By contrast, the oxidoreductase FSP1
Recommended publications
  • Relating Metatranscriptomic Profiles to the Micropollutant
    1 Relating Metatranscriptomic Profiles to the 2 Micropollutant Biotransformation Potential of 3 Complex Microbial Communities 4 5 Supporting Information 6 7 Stefan Achermann,1,2 Cresten B. Mansfeldt,1 Marcel Müller,1,3 David R. Johnson,1 Kathrin 8 Fenner*,1,2,4 9 1Eawag, Swiss Federal Institute of Aquatic Science and Technology, 8600 Dübendorf, 10 Switzerland. 2Institute of Biogeochemistry and Pollutant Dynamics, ETH Zürich, 8092 11 Zürich, Switzerland. 3Institute of Atmospheric and Climate Science, ETH Zürich, 8092 12 Zürich, Switzerland. 4Department of Chemistry, University of Zürich, 8057 Zürich, 13 Switzerland. 14 *Corresponding author (email: [email protected] ) 15 S.A and C.B.M contributed equally to this work. 16 17 18 19 20 21 This supporting information (SI) is organized in 4 sections (S1-S4) with a total of 10 pages and 22 comprises 7 figures (Figure S1-S7) and 4 tables (Table S1-S4). 23 24 25 S1 26 S1 Data normalization 27 28 29 30 Figure S1. Relative fractions of gene transcripts originating from eukaryotes and bacteria. 31 32 33 Table S1. Relative standard deviation (RSD) for commonly used reference genes across all 34 samples (n=12). EC number mean fraction bacteria (%) RSD (%) RSD bacteria (%) RSD eukaryotes (%) 2.7.7.6 (RNAP) 80 16 6 nda 5.99.1.2 (DNA topoisomerase) 90 11 9 nda 5.99.1.3 (DNA gyrase) 92 16 10 nda 1.2.1.12 (GAPDH) 37 39 6 32 35 and indicates not determined. 36 37 38 39 S2 40 S2 Nitrile hydration 41 42 43 44 Figure S2: Pearson correlation coefficients r for rate constants of bromoxynil and acetamiprid with 45 gene transcripts of ECs describing nucleophilic reactions of water with nitriles.
    [Show full text]
  • Substrate-Mediated Reduction of the Diiron Center for 5-Demethoxyubiquinone Hydroxylation
    Aging-Associated Enzyme Human Clock-1: Substrate-Mediated Reduction of the Diiron Center for 5-Demethoxyubiquinone Hydroxylation The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Lu, Tsai-Te, Seung Jae Lee, Ulf-Peter Apfel, and Stephen J. Lippard. “Aging-Associated Enzyme Human Clock-1: Substrate-Mediated Reduction of the Diiron Center for 5-Demethoxyubiquinone Hydroxylation.” Biochemistry 52, no. 13 (April 2, 2013): 2236–2244. As Published http://dx.doi.org/10.1021/bi301674p Publisher American Chemical Society (ACS) Version Author's final manuscript Citable link http://hdl.handle.net/1721.1/95488 Terms of Use Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. NIH Public Access Author Manuscript Biochemistry. Author manuscript; available in PMC 2014 April 02. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Biochemistry. 2013 April 2; 52(13): 2236–2244. doi:10.1021/bi301674p. Aging-Associated Enzyme Human Clock-1: Substrate-Mediated Reduction of the Diiron Center for 5-Demethoxyubiquinone Hydroxylation† Tsai-Te Lu, Seung Jae Lee, Ulf-Peter Apfel, and Stephen J. Lippard* Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, United States Abstract The mitochondrial membrane-bound enzyme Clock-1 (CLK-1) extends the average longevity of mice and C. elegans, as demonstrated for Δclk-1 constructs for both organisms. Such an apparent impact on aging and the presence of a carboxylate-bridged diiron center in the enzyme inspired the present work.
    [Show full text]
  • Electronic Supplementary Material (ESI) for Metallomics
    Electronic Supplementary Material (ESI) for Metallomics. This journal is © The Royal Society of Chemistry 2018 Uniprot Entry name Gene names Protein names Predicted Pattern Number of Iron role EC number Subcellular Membrane Involvement in disease Gene ontology (biological process) Id iron ions location associated 1 P46952 3HAO_HUMAN HAAO 3-hydroxyanthranilate 3,4- H47-E53-H91 1 Fe cation Catalytic 1.13.11.6 Cytoplasm No NAD biosynthetic process [GO:0009435]; neuron cellular homeostasis dioxygenase (EC 1.13.11.6) (3- [GO:0070050]; quinolinate biosynthetic process [GO:0019805]; response to hydroxyanthranilate oxygenase) cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]; tryptophan (3-HAO) (3-hydroxyanthranilic catabolic process [GO:0006569] acid dioxygenase) (HAD) 2 O00767 ACOD_HUMAN SCD Acyl-CoA desaturase (EC H120-H125-H157-H161; 2 Fe cations Catalytic 1.14.19.1 Endoplasmic Yes long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; unsaturated fatty 1.14.19.1) (Delta(9)-desaturase) H160-H269-H298-H302 reticulum acid biosynthetic process [GO:0006636] (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) (hSCD1) 3 Q6ZNF0 ACP7_HUMAN ACP7 PAPL PAPL1 Acid phosphatase type 7 (EC D141-D170-Y173-H335 1 Fe cation Catalytic 3.1.3.2 Extracellular No 3.1.3.2) (Purple acid space phosphatase long form) 4 Q96SZ5 AEDO_HUMAN ADO C10orf22 2-aminoethanethiol dioxygenase H112-H114-H193 1 Fe cation Catalytic 1.13.11.19 Unknown No oxidation-reduction process [GO:0055114]; sulfur amino acid catabolic process (EC 1.13.11.19) (Cysteamine
    [Show full text]
  • Mechanistic Study of Cysteine Dioxygenase, a Non-Heme
    MECHANISTIC STUDY OF CYSTEINE DIOXYGENASE, A NON-HEME MONONUCLEAR IRON ENZYME by WEI LI Presented to the Faculty of the Graduate School of The University of Texas at Arlington in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY THE UNIVERSITY OF TEXAS AT ARLINGTON August 2014 Copyright © by Student Name Wei Li All Rights Reserved Acknowledgements I would like to thank Dr. Pierce for your mentoring, guidance and patience over the five years. I cannot go all the way through this without your help. Your intelligence and determination has been and will always be an example for me. I would like to thank my committee members Dr. Dias, Dr. Heo and Dr. Jonhson- Winters for the directions and invaluable advice. I also would like to thank all my lab mates, Josh, Bishnu ,Andra, Priyanka, Eleanor, you all helped me so I could finish my projects. I would like to thank the Department of Chemistry and Biochemistry for the help with my academic and career. At Last, I would like to thank my lovely wife and beautiful daughter who made my life meaningful and full of joy. July 11, 2014 iii Abstract MECHANISTIC STUDY OF CYSTEINE DIOXYGENASE A NON-HEME MONONUCLEAR IRON ENZYME Wei Li, PhD The University of Texas at Arlington, 2014 Supervising Professor: Brad Pierce Cysteine dioxygenase (CDO) is an non-heme mononuclear iron enzymes that catalyzes the O2-dependent oxidation of L-cysteine (Cys) to produce cysteine sulfinic acid (CSA). CDO controls cysteine levels in cells and is a potential drug target for some diseases such as Parkinson’s and Alzhermer’s.
    [Show full text]
  • Springer Handbook of Enzymes
    Dietmar Schomburg and Ida Schomburg (Eds.) Springer Handbook of Enzymes Volume 25 Class 1 • Oxidoreductases X EC 1.9-1.13 co edited by Antje Chang Second Edition 4y Springer Index of Recommended Enzyme Names EC-No. Recommended Name Page 1.13.11.50 acetylacetone-cleaving enzyme 673 1.10.3.4 o-aminophenol oxidase 149 1.13.12.12 apo-/?-carotenoid-14',13'-dioxygenase 732 1.13.11.34 arachidonate 5-lipoxygenase 591 1.13.11.40 arachidonate 8-lipoxygenase 627 1.13.11.31 arachidonate 12-lipoxygenase 568 1.13.11.33 arachidonate 15-lipoxygenase 585 1.13.12.1 arginine 2-monooxygenase 675 1.13.11.13 ascorbate 2,3-dioxygenase 491 1.10.2.1 L-ascorbate-cytochrome-b5 reductase 79 1.10.3.3 L-ascorbate oxidase 134 1.11.1.11 L-ascorbate peroxidase 257 1.13.99.2 benzoate 1,2-dioxygenase (transferred to EC 1.14.12.10) 740 1.13.11.39 biphenyl-2,3-diol 1,2-dioxygenase 618 1.13.11.22 caffeate 3,4-dioxygenase 531 1.13.11.16 3-carboxyethylcatechol 2,3-dioxygenase 505 1.13.11.21 p-carotene 15,15'-dioxygenase (transferred to EC 1.14.99.36) 530 1.11.1.6 catalase 194 1.13.11.1 catechol 1,2-dioxygenase 382 1.13.11.2 catechol 2,3-dioxygenase 395 1.10.3.1 catechol oxidase 105 1.13.11.36 chloridazon-catechol dioxygenase 607 1.11.1.10 chloride peroxidase 245 1.13.11.49 chlorite O2-lyase 670 1.13.99.4 4-chlorophenylacetate 3,4-dioxygenase (transferred to EC 1.14.12.9) .
    [Show full text]
  • Transcriptome Analysis of Pistacia Vera Inflorescence Buds in Bearing
    G C A T T A C G G C A T genes Article Transcriptome Analysis of Pistacia vera Inflorescence Buds in Bearing and Non-Bearing Shoots Reveals the Molecular Mechanism Causing Premature Flower Bud Abscission Jubina Benny 1, Francesco Paolo Marra 2,* , Antonio Giovino 3, Bipin Balan 1,4, Tiziano Caruso 1, Federico Martinelli 5 and Annalisa Marchese 1,* 1 Department of Agricultural, Food and Forest Sciences, University of Palermo, Viale delle Scienze—Ed. 4, 90128 Palermo, Italy; [email protected] (J.B.); [email protected] (B.B.); [email protected] (T.C.) 2 Department of Architecture (DARCH), University of Palermo, Viale delle Scienze—Ed. 8, 90128 Palermo, Italy 3 Council for Agricultural Research and Economics (CREA), Research Centre for Plant Protection and Certification (CREA-DC), 90011 Bagheria, Italy; [email protected] 4 Department of Plant Sciences, University of California, Davis, CA 95616, USA 5 Department of Biology, University of Florence, Sesto Fiorentino, 50019 Florence, Italy; federico.martinelli@unifi.it * Correspondence: [email protected] (F.P.M.); [email protected] (A.M.) Received: 23 June 2020; Accepted: 23 July 2020; Published: 25 July 2020 Abstract: The alteration of heavy (“ON/bearing”) and light (“OFF/non-bearing”) yield in pistachio (Pistacia vera L.) has been reported to result from the abscission of inflorescence buds on high yielding trees during the summer, but the regulatory mechanisms involved in this bud abscission remain unclear. The analysis provides insights into the transcript changes between inflorescence buds on bearing and non-bearing shoots, that we indicated as “ON” and “OFF”, and shed light on the molecular mechanisms causing premature inflorescence bud abscission in the pistachio cultivar “Bianca” which can be related to the alternate bearing behavior.
    [Show full text]
  • And Fe(II)-Dependent Oxygenase Superfamily Protein(AT4G10500)
    AGI code Name At4g10500 2-oxoglutarate (2OG) and Fe(II)-dependent oxygenase superfamily protein(AT4G10500) GOTERM_BP_DIRECT defense response to oomycetes, response to oomycetes, response to bacterium, response to fungus, response to salicylic acid, leaf senescence, secondary metabolic process, salicylic acid catabolic process, oxidation-reduction process, GOTERM_MF_DIRECT oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors, metal ion binding, dioxygenase activity, At5g59540 2-oxoglutarate (2OG) and Fe(II)-dependent oxygenase superfamily protein(AT5G59540) GOTERM_BP_DIRECT oxidation-reduction process, GOTERM_CC_DIRECT cytoplasm, GOTERM_MF_DIRECT oxidoreductase activity, metal ion binding, dioxygenase activity, At3g55090 ABC-2 type transporter family protein(ABCG16) GOTERM_BP_DIRECT pollen wall assembly, GOTERM_CC_DIRECT plasma membrane, integral component of membrane, GOTERM_MF_DIRECT ATP binding, ATPase activity, coupled to transmembrane movement of substances, At2g37360 ABC-2 type transporter family protein(ABCG2) GOTERM_BP_DIRECT transport, suberin biosynthetic process, GOTERM_CC_DIRECT plasma membrane, integral component of membrane, GOTERM_MF_DIRECT ATP binding, ATPase activity, ATPase activity, coupled to transmembrane movement of substances, At3g47780 ABC2 homolog 6(ABCA7) GOTERM_BP_DIRECT lipid transport, GOTERM_CC_DIRECT plasma membrane, plasmodesma, integral component of membrane, intracellular
    [Show full text]
  • Supplementary Material
    Table S1 . Genes up-regulated in the CL of stimulated in relation to control animals ( 1.5 fold, P ≤ 0.05). UniGene ID Gene Title Gene Symbol fold change P value Bt.16350.2.A1_s_at guanylate binding protein 5 GBP5 4.42 0.002 Bt.2498.2.A1_a_at fibrinogen gamma chain FGG 3.81 0.002 Bt.440.1.S1_at neurotensin NTS 3.74 0.036 major histocompatibility complex, class I, A /// major Bt.27760.1.S1_at histocompatibility complex, class I, A BoLA /// HLA-A 3.56 0.022 Bt.146.1.S1_at defensin, beta 4A DEFB4A 3.12 0.002 Bt.7165.1.S1_at chemokine (C-X-C motif) ligand 5 CXCL5 3.06 0.031 Bt.15731.1.A1_at V-set and immunoglobulin domain containing 4 VSIG4 3.03 0.047 Bt.22869.1.S2_at fatty acid binding protein 5 (psoriasis-associated) FABP5 3.02 0.006 Bt.4604.1.S1_a_at acyl-CoA synthetase medium-chain family member 1 ACSM1 2.93 0.001 Bt.6406.1.S3_at CCAAT/enhancer binding protein (C/EBP), delta CEBPD 2.92 0.011 Bt.19845.2.A1_at coagulation factor XIII, A1 polypeptide F13A1 2.83 0.005 Bt.209.3.S1_at lysozyme (renal amyloidosis) LYZ 2.77 0.0003 Bt.15908.1.S1_at methyltransferase like 7A METTL7A 2.59 0.007 Bt.28383.1.S1_at granulysin GNLY 2.58 0.034 Bt.20455.1.S1_at Microtubule-associated protein tau MAPT 2.56 0.047 Bt.6556.1.S1_at regakine 1 LOC504773 2.55 0.011 Bt.11259.1.S1_at putative ISG12(a) protein ISG12(A) 2.55 0.037 Bt.28243.1.S1_a_at vanin 1 VNN1 2.54 0.008 Bt.405.1.S1_at follistatin FST 2.52 0.002 Bt.9510.2.A1_a_at T-cell immunoglobulin and mucin domain containing 4 TIMD4 2.47 0.024 Bt.499.1.S1_a_at prolactin receptor PRLR 2.44 0.010 serpin peptidase
    [Show full text]
  • Inositol and Higher Inositol Phosphates in Neural Tissues: Homeostasis, Metabolism and Functional Significance
    Journal of Neurochemistry, 2002, 82, 736–754 REVIEW Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance Stephen K. Fisher,*, James E. Novak*, and Bernard W. Agranoff*,à *Mental Health Research Institute, and Departments of Pharmacology, and àBiochemistry and Psychiatry, University of Michigan, Ann Arbor, Michigan, USA Abstract its hexakisphosphate and pyrophosphorylated derivatives Inositol phospholipids and inositol phosphates mediate well- may play roles in such diverse cellular functions as DNA established functions in signal transduction and in Ca2+ repair, nuclear RNA export and synaptic membrane traf- homeostasis in the CNS and non-neural tissues. More ficking. recently, there has been renewed interest in other roles that Keywords: affective disorder and treatment, diphosphoino- both myo-inositol and its highly phosphorylated forms may sitol polyphosphates, inositol hexakisphosphate, lithium, Na+/ play in neural function. We review evidence that myo-inositol myo-inositol transporter, phytate. serves as a clinically relevant osmolyte in the CNS, and that J. Neurochem. (2002) 82, 736–754. The prominent role of inositol phospholipids in signal (namely, inositol hexakisphosphate and the diphosphoino- transduction events within the CNS is now well established sitol polyphosphates) may play in neural function. The CNS (for reviews, see Fisher and Agranoff 1987; Fisher et al. is an atypical tissue in that it possesses relatively high 1992). In addition, roles for phosphoinositides as facilitators concentrations of myo-inositol as well as the means to of a diverse array of cellular events, such as membrane synthesize it. myo-Inositol serves not only as a precursor trafficking, maintenance of the actin cytoskeleton, regulation molecule for inositol lipid synthesis, but also as a physi- of cell death and survival, and anchors for plasma membrane ologically important osmolyte.
    [Show full text]
  • Mrna Expression in Human Leiomyoma and Eker Rats As Measured by Microarray Analysis
    Table 3S: mRNA Expression in Human Leiomyoma and Eker Rats as Measured by Microarray Analysis Human_avg Rat_avg_ PENG_ Entrez. Human_ log2_ log2_ RAPAMYCIN Gene.Symbol Gene.ID Gene Description avg_tstat Human_FDR foldChange Rat_avg_tstat Rat_FDR foldChange _DN A1BG 1 alpha-1-B glycoprotein 4.982 9.52E-05 0.68 -0.8346 0.4639 -0.38 A1CF 29974 APOBEC1 complementation factor -0.08024 0.9541 -0.02 0.9141 0.421 0.10 A2BP1 54715 ataxin 2-binding protein 1 2.811 0.01093 0.65 0.07114 0.954 -0.01 A2LD1 87769 AIG2-like domain 1 -0.3033 0.8056 -0.09 -3.365 0.005704 -0.42 A2M 2 alpha-2-macroglobulin -0.8113 0.4691 -0.03 6.02 0 1.75 A4GALT 53947 alpha 1,4-galactosyltransferase 0.4383 0.7128 0.11 6.304 0 2.30 AACS 65985 acetoacetyl-CoA synthetase 0.3595 0.7664 0.03 3.534 0.00388 0.38 AADAC 13 arylacetamide deacetylase (esterase) 0.569 0.6216 0.16 0.005588 0.9968 0.00 AADAT 51166 aminoadipate aminotransferase -0.9577 0.3876 -0.11 0.8123 0.4752 0.24 AAK1 22848 AP2 associated kinase 1 -1.261 0.2505 -0.25 0.8232 0.4689 0.12 AAMP 14 angio-associated, migratory cell protein 0.873 0.4351 0.07 1.656 0.1476 0.06 AANAT 15 arylalkylamine N-acetyltransferase -0.3998 0.7394 -0.08 0.8486 0.456 0.18 AARS 16 alanyl-tRNA synthetase 5.517 0 0.34 8.616 0 0.69 AARS2 57505 alanyl-tRNA synthetase 2, mitochondrial (putative) 1.701 0.1158 0.35 0.5011 0.6622 0.07 AARSD1 80755 alanyl-tRNA synthetase domain containing 1 4.403 9.52E-05 0.52 1.279 0.2609 0.13 AASDH 132949 aminoadipate-semialdehyde dehydrogenase -0.8921 0.4247 -0.12 -2.564 0.02993 -0.32 AASDHPPT 60496 aminoadipate-semialdehyde
    [Show full text]
  • A Meta-Analysis of the Effects of High-LET Ionizing Radiations in Human Gene Expression
    Supplementary Materials A Meta-Analysis of the Effects of High-LET Ionizing Radiations in Human Gene Expression Table S1. Statistically significant DEGs (Adj. p-value < 0.01) derived from meta-analysis for samples irradiated with high doses of HZE particles, collected 6-24 h post-IR not common with any other meta- analysis group. This meta-analysis group consists of 3 DEG lists obtained from DGEA, using a total of 11 control and 11 irradiated samples [Data Series: E-MTAB-5761 and E-MTAB-5754]. Ensembl ID Gene Symbol Gene Description Up-Regulated Genes ↑ (2425) ENSG00000000938 FGR FGR proto-oncogene, Src family tyrosine kinase ENSG00000001036 FUCA2 alpha-L-fucosidase 2 ENSG00000001084 GCLC glutamate-cysteine ligase catalytic subunit ENSG00000001631 KRIT1 KRIT1 ankyrin repeat containing ENSG00000002079 MYH16 myosin heavy chain 16 pseudogene ENSG00000002587 HS3ST1 heparan sulfate-glucosamine 3-sulfotransferase 1 ENSG00000003056 M6PR mannose-6-phosphate receptor, cation dependent ENSG00000004059 ARF5 ADP ribosylation factor 5 ENSG00000004777 ARHGAP33 Rho GTPase activating protein 33 ENSG00000004799 PDK4 pyruvate dehydrogenase kinase 4 ENSG00000004848 ARX aristaless related homeobox ENSG00000005022 SLC25A5 solute carrier family 25 member 5 ENSG00000005108 THSD7A thrombospondin type 1 domain containing 7A ENSG00000005194 CIAPIN1 cytokine induced apoptosis inhibitor 1 ENSG00000005381 MPO myeloperoxidase ENSG00000005486 RHBDD2 rhomboid domain containing 2 ENSG00000005884 ITGA3 integrin subunit alpha 3 ENSG00000006016 CRLF1 cytokine receptor like
    [Show full text]
  • Open Dissertation Rajakovichlj.Pdf
    The Pennsylvania State University The Graduate School Eberly College of Science EXPLORING THE FUNCTIONAL AND MECHANISTIC DIVERSITY OF DIIRON OXIDASES AND OXYGENASES A Dissertation in Biochemistry, Microbiology, and Molecular Biology by Lauren J. Rajakovich 2017 Lauren J. Rajakovich Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy December 2017 ii The dissertation of Lauren J. Rajakovich was reviewed and approved* by the following: J. Martin Bollinger, Jr. Professor of Chemistry Professor of Biochemistry and Molecular Biology Dissertation Co-Advisor Committee Co-Chair Carsten Krebs Professor of Chemistry Professor of Biochemistry and Molecular Biology Dissertation Co-Advisor Committee Co-Chair Squire J. Booker Howard Hughes Medical Investigator Professor of Chemistry Professor of Biochemistry and Molecular Biology Amie K. Boal Professor of Chemistry Professor of Biochemistry and Molecular Biology Christopher House Professor of Geosciences Scott Selleck Professor of Biochemistry and Molecular Biology Head of the Department of Biochemistry, Microbiology, and Molecular Biology *Signatures are on file in the Graduate School iii ABSTRACT Approximately half of all enzymes in Nature utilize a metal to perform their biological function. Many of the metalloenzymes that harbor transition metals activate dioxygen to catalyze a diverse array of oxidation reactions to functionalize unreactive sites in biomolecules. These enzymatic transformations are often inaccessible to synthetic chemists, and consequently, understanding the naturally-evolved mechanisms by which these enzymes enact such challenging reactions will enable the development of new biocatalysts for industrial and therapeutic applications. One common strategy employed in Nature is the coupling of two transition metals, typically iron, to carry out oxidation and oxygenation reactions.
    [Show full text]